Research Topics
| Nananda F ColSummaryAffiliation: Maine Medical Center Country: USA Publications
|
Detail Information
Publications
Duration of vasomotor symptoms in middle-aged women: a longitudinal studyNananda F Col
Center for Outcomes Research and Evaluation, Maine Medical Center, Portland, ME 04101, USA
Menopause 16:453-7. 2009..The most effective treatment, hormone therapy (HT), carries risks and benefits that depend on the timing and duration of use. In this study we sought to estimate the duration of vasomotor symptoms in a longitudinal study...
Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer riskNananda F Col
Center for Outcomes Research and Evaluation, Maine Medical Center, Portland, ME 04101, USA
Menopause 15:804-9. 2008..A simple algorithm is presented to streamline identification and management of menopausal women at high risk for breast cancer...
Can computerized decision support help patients make complex treatment decisions? A randomized controlled trial of an individualized menopause decision aidNananda F Col
Brown Medical School, Providence, Rhode Island, USA
Med Decis Making 27:585-98. 2007....
Revisiting the duration of vasomotor symptoms of menopause: a meta-analysisMary C Politi
Department of Behavioral and Preventive Medicine, Brown Medical School, Providence, RI 02903, USA
J Gen Intern Med 23:1507-13. 2008..Treatment decisions about menopause are predicated on a transient duration of vasomotor symptoms. However, evidence supporting a specific duration is weak...
Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidenceNananda F Col
Brown Medical School, Providence, Rhode Island, USA
Breast Cancer Res 7:R535-40. 2005..Our objectives were to estimate the effects of HT on recurrence in breast cancer survivors and to examine the reliability of these estimates...
The impact of risk status, preexisting morbidity, and polypharmacy on treatment decisions concerning menopausal symptomsNananda F Col
Department of Medicine, Brown University, Providence, Rhode Island, USA
Am J Med 118:155-62. 2005..More data are needed about the effects of menopausal treatments in diverse populations, and more attention is needed to translate this evidence into clinical practice and to develop tools to support informed decision making...
Communicating the uncertainty of harms and benefits of medical interventionsMary C Politi
Brown Medical School Rhode Island Hospital, Providence, Rhode Island, USA
Med Decis Making 27:681-95. 2007..Little is known about the optimal approaches to or outcomes of communicating uncertainty about the risks and benefits of treatments...
Hormone therapy for the prevention of bone loss in menopausal women with osteopenia: is it a viable option?Mary H Hohenhaus
Department of Medicine, Brown University, The Miriam Hospital, Providence, Rhode Island 02906, USA
Drugs 67:2311-21. 2007..For osteopenic women with higher risk, the availability of other treatments with a more favourable risk-benefit profile eliminates the role of hormone therapy for fracture prevention...
Commentary--surgical decisions after breast cancer: can patients be too involved in decision making?Nananda F Col
Department of Medicine, Brown Medical School and Rhode Island Hospital, MPB 1, 593 Eddy St, Providence, Rhode Island 02903, USA
Health Serv Res 40:769-79. 2005
Short-term menopausal hormone therapy for symptom relief: an updated decision modelNananda F Col
Division of General Internal Medicine, Rhode Island Hospital, Brown Medical School, Providence 02903, USA
Arch Intern Med 164:1634-40. 2004..Our objective was to identify which women should benefit from short-term HT by exploring the trade-off between symptom relief and risks of inducing disease...
